Detection of Thyroid Cancer and Central Lymph Node Metastases Using EMI-137 Enhanced Molecular Fluorescent Guided Surgery: a Multicentre Feasibility study
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2019
Price : $35 *
At a glance
- Drugs EMI-137 (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions
- Acronyms TARGET
- 29 Oct 2019 Planned End Date changed from 1 Apr 2020 to 1 Jul 2020.
- 29 Oct 2019 Planned primary completion date changed from 1 Oct 2019 to 1 Jan 2020.
- 31 Aug 2018 Biomarkers information updated